Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Steve Fancy who wrote (2579)	10/31/1997 5:06:00 AM
From: James Baker	Read Replies (1) of 6136

From: Steve Fancy Friday, Oct 31 1997 2:56AM EST Reply #2579 of 2579 Pennsylvania Adds Agouron's Viracept To AIDS Treatment Program Dow Jones Online News, Thursday, October 30, 1997 at 18:30 HARRISBURG, Pa. -(Dow Jones)- The Pennsylvania State Public Welfare Department said Thursday it will add Viracept, a protease inhibitor, to its Special Pharmaceutical Benefits Program to treat HIV/AIDS patients. Viracept is manufactured by Agouron Pharmaceuticals Inc. (AGPH>>> I agree every bit like this helps AGPH. I wonder if anyone knows if other PI's are already covered by the PA program or if Viracept is added as the only PI covered??? Jim

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next